Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury

H

Hamamatsu University

Status

Unknown

Conditions

Kidney Failure

Study type

Observational

Funder types

Other

Identifiers

NCT00310739
16-50

Details and patient eligibility

About

We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat. The purpose of this clinical study is to test whether the changes of human urinary excretion of MDA, and can be used as early biomarker for the prediction of development of CDDP-induced ARF.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Hospitalized patients have neck cancer

Trial contacts and locations

0

Loading...

Central trial contact

Takayuki Tsuji, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems